Original Article


IBBJ                                                                                                  

Winter 2015, Vol 1, No 1

 

 

Oligohydramnios and pregnancy outcome: Ten-years re­view

Nesa Asnafi1, 2, Zinatossadat Bouzari2, 3*, Maede Mohammadnetadj4

 

1. Infertility and Reproductive Health Research Center, Babol University of Medical sciences, Babol Iran

2. Department of Obstetrics & Gynecology of Babol University of Medical Sciences, Babol, Iran

3. Cellular & Molecular Biology Research Center, Babol University of Medical sciences, Babol Iran

4. Mazandaran University of Babolsar, Babolsar, Iran

 

Submitted 18 Oct  2014; Accepted 17 Nov 2014;Published 4 Feb 2015

Oligohydramnios is frequently used to identify at risk fetuses. The purpose of this study was to assess adverse perinatal outcomes in oligohydramnios. Subjects comprised preg­nant women diagnosed either with (590) or without (597) oligohydramnios who deliv­ered after hospital admittance from 2000 to 2010 . Data, including the resuscitation of newborn, Apgar score at 5 min, NICU admission, death in 24 hours after birth,  still birth, intrauterine growth restriction, fetal distress, meconium passage, and neonatal birth weight were abstracted from records. Chi – square, Fisher’s exact test, and t tests were used for analysis. An amniotic fluid index of 5 cm or less had a higher rate of me­coni­um passage. Antepartum oligohydramnios is asso­ciated with an increased risk of perinatal morbidity and mortality.

 

Key Words: Oligohydramnios, intrauterine growth restriction, still birth

 

 


 


*Corresponding author:  Zinatossadat Bouzari,

Department of Obstetrics & Gynecology of Babol University of Medical Sciences, Babol, Iran

Cellular & Molecular Biology Research Center, Babol University of Medical sciences, Babol Iran

Email: z_b412003@yahoo.com

 

 




U

nder normal conditions, amniotic fluid volume increases linearly until about 36 weeks of pregnancy, which is average rate is 1000 mL and then it's volume decreases to less than 200 mL at 42 weeks. In the past decade a number of ultrasound methods have been used to measure the amount of amniotic fluid (1). The amniotic fluid index (AFI), as measured by the four– quadrant ultrasonic technique was added to antepartum testing to better identify fetuses at higher risk of poor perinatal outcome (2). The amniotic fluid index of less than 5 cm is termed oligohydramnios (1). Oligohydramnios involves 3- 5% of pregnancies (3).

 

Generally, oligohydramnios is less prevalent in early pregnancy and at this time it usually is associated with poor prognosis (1). In uncomplicated pregnancies at 40.0 to 41.6 weeks, oligohydramnios is independently associated with a higher risk of low birth weight per centile (4). Also in multiple studies oligohydramnios has been correlated with increased risk of abnormal fetal heart rate (5-8), pulmonary hypoplasia (9, 10), increased risk of cesarean delivery (5), intrauterine growth restriction (IUGR) (7, 11), postdate pregnancy, meconium passage, lower Apgar scores (7), stillbirth, admission to the neonatal intensive care unit (NICU) and neonatal death (8). Thus, in high risk pregnancies, oligohydramnios is frequently used to identify fetuses at risk of an adverse outcome.

The purpose of this study was to evaluate the effect of oligohydramnios on perinatal outcome.

 

 

    Materials & Methods                                               

 This retrospective study was performed on pregnant women who were admitted in Yahyanejad  and Ayatolah Rohani Hospitals at Babol Medical University, Babol, Iran, between 2000 and 2010. In this study, we reviewed records of women either with or without oligohydramnios who were admitted and delivered . Exclusion criteria included women with multiple pregnancies, fetal anomaly  and lack of complete information in the records. All women with oligohydramnios who delivered were entered in the study, whereas women without oligohydramnios were obtained by systematic random sampling in every year.

 

In our study oligohydramnios was defined as the index of amniotic fluid ≤ 5 cm (1). Gestational age was calculated from the first day of the last menstrual period (LMP) and if women were unsure of their LMP, the gestational age was determined by ultrasound scan performed before 20 weeks of pregnancy. Women were categorized into five groups based on gestational age including: immature (< 28 weeks), preterm (28- 33 weeks± 6 days), late preterm (34- 36 weeks± 6 days), term (37- 39 weeks± 6 days), postterm (≥ 40 weeks) (12). Birth weight percentile was obtained from growth chart (13). Apgar score at 5 min was divided into three groups: Apgar score ≤ 3, Apgar score 4- 7 (needed resuscitation of newborn)  and Apgar score ≥ 8 (normal) (14). Fetal distress (FD) was diagnosed by the attending obstetrician on the basis of fetal heart abnormality not corrected with left lateral position, hydration and nasal oxygen. Neonatal data taken out of the records included: resuscitation of newborn, Apgar score at 5 min, NICU admission, death in 24 hours after birth, still birth, IUGR, FD, meconium passage, and neonatal birth weight.

 

Statistical analyzes: Data were col­lected, coded and entered into the SPSS statistical software version 18. Statistical analyzes were per­formed with the Chi-square test, Fisher´s exact test, and Student T- test. Statistical significance was consid­ered at P< 0.05.

 

    Results                                                            

  

 In this study we reviewed 36872 deliveries in Babol Yahyanejad and Ayatolah Rohani Hospitals during the years 2000 to 2010.

 

 

    Table 1. Mean gestational age in women with and without oligohydramnios

Sig.

Mean± SD (weeks)

N

AFI* (cm)

Gestational age

0.62

33.63± 3.27

126

≤ 5

Preterm

33.82± 2.92

147

≥5

0.76

38.13± 0.76

210

≤5

Term

38.11± 0.75

234

≥5

0.09

40.52± 0.62

254

≤5

Post term

40.42± 0.06

216

≥5


 

 

After considering exclusion criteria, the number of pregnancies with and without oligohydramnios were 590 and 597 respectively. The mean age of women with AFI≤ 5 cm and normal AFI were 24.86± 5.69 and 26.51± 6.16 years respectively. There was a significant difference between maternal age in the two groups (P< 0.001).The mean pregnancy age in oligohydramnios and AFI greater than 5 groups were 38.20± 3.07 and 37.89± 2.98 weeks, respectively. There was no significant difference between pregnancy ages among the two groups (P= 0.079) (Table 1).

 

 

    Table 2. Frequency of women with and without oligohydramnios based on gestational age

P- value

Post term

N (%)

Term

N (%)

Preterm

N (%)

 

0.051

254 (43.1)

210 (35.6)

126 (21.4)

AFI≤ 5 cm

216 (36.2)

243 (39.2)

147 (24.6)

AFI= N


 

 

 

Using the growth charts; birth weight in both groups were in 10- 90th percentile and there was no difference in prevalence of infants with small for gestational age (SGA), appropriate for gestational age (AGA) and large for gestational age (LGA) between the two groups. Frequency of women with and without oligohydramnios based on gestational age did not differ significantly (Table 1).

 

Neonatal outcomes in oligohydramnios and normal amniotic fluid based on gestational age were  analyzed and there were statistical significant differences in resuscitation of newborn (P=0.02), admission in NICU(P=0.001), death in 24 hours after birth (P= 0.024), IUGR (P= 0.001), and meconium passage (P= 0.008) between the two groups for preterm delivery. Also the two groups differed in resuscitation of newborn (P= 0.029), NICU admission (P=0.011),

 

 

 

    Table 3. Neonatal outcome in pregnant women with and without oligohydramnios based on gestational age

Post term

Term

Preterm

Neonatal outcome

 

P-value

AFI= N

AFI≤ 5 cm

P-value

AFI= N

AFI≤ 5 cm

P-value

AFI= N

AFI≤ 5cm

 

 

0.52

6

(2.8)

4

(1.6)

0.029*

1

(0.4)

7

(3.3)

0.02*

12

(8.2)

22

(17.5)

Resuscitation of newborn

 

0.162

9

(4.2)

5

(2.0)

0.011

2

(0.9)

10

(4.8)

0.001

12

(8.2)

29

(23.0)

Admitted in NICU

 

0.46*

1

(0.5)

0

(0.0)

0.47*

 

0

(0.0)

1

(0.5)

0.044*

0

(0.0)

4

(3.2)

Death in 24 hours after birth

 

0.43*

1

(0.5)

0

(0.0)

_

_

_

0.47*

0

(0.0)

1

(0.8)

Still birth

 

0.56

8

(3.7)

7

(2.8)

0.001

1

(0.4)

15

(7.1)

0.001

16

(10.9)

33

(26.2)

IUGR

 

0.002

57

(26.4)

101

(39.8)

0.001

28

(12.0)

78

(37.1)

0.156

47

(32.2)

51

(40.0)

Fetal distress

 

0.137

57

(26.4)

83

(32.1)

0.008

31

(13.2)

48

(22.9)

0.008

43

(29.7)

57

(45.2)

Meconium passage

 


    *Fisher´s Exact test

 


IUGR (P= 0.001), fetal distress (P= 0.001) and meconium passage (P= 0.008) in term delivery, but no statistical significant difference existed between the groups for gestational age ≥ 40 weeks except for fetal distress (P= 0.002). Still birth was not associated with oligohydramnios in preterm, term, and postdate delivery(Table 3).

Comparison of neonatal Apgar score at 5 min, between pregnant women with and without oligohydramnios based on gestational age showed that there was a statistical significant difference in low Apgar preterm and term neonates between the two groups but not in postdate neonate (Table 4).

 

    Table 4. Neonatal Apgar score at 5 min in pregnant women with and without oligohydramnios based on gestational age

Post date

Term

Preterm

Apgar score

at 5 min

P-value

AFI= N

AFI≤ 5 cm

P-value

AFI= N

AFI≤ 5 cm

P-value

AFI= N

AFI≤ 5cm

 

 

1

(0.5)

0

(0.0)

_

_

3

(0.2)

4

(3.2)

<3

 

0.28

8

(3.7)

5

(2.0)

0.024

4

(1.7)

12

(5.7)

0.045

17

(11.6)

28

(22.2)

4-7

 

207

(95.8)

249

(98.0)

 

230

(98.3)

198

(94.3)

127

(86.4)

94

(74.6)

≥ 8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Discussion                                                     

 

 In order to improve antepartum risk assessment, AFI was measured in addition to non- stress testing. There is a higher risk of perinatal morbidity in women presenting oligohydramnios which is a delivery indication (15). In oligohydramnios due to pressure on the umbilical cord, fetal distress increases and probably the newborn will be delivered with a low Apgar score. In the present study, a statistical significant difference of FD in AFI≤ 5 cm and normal AFI in term and postdate pregnancies was observed. Similar to our study, Alchalabi et al. reported that FD was increased among women with reduced fluid (AFI≤ 5 cm) compared to those with liquor (AF> 5 cm) in 37- 42 weeks gestational age (5). Also, Locatelli et al. showed that women with AFI≤ 5 cm had higher rate of cesarean section because of non- reassuring fetal heart rate tracing  (4). In another study for 27 to 43 weeks gestational age, there was a significantly higher rate of abnormal FHR tracings in women with AFI less than or equal to 5 cm (7). 

 

In the present study, meconium passage was statistically higher in both groups at preterm and term delivery While Golan et al. reported %29 meconium passage in pregnancy with oligohydramnios  and %10.7 death (16). Alchalabi et al. in a prospective study have reported the meconium passage in %7 pregnancies with oligohydramnios which was similar to our study (5).

 

In our study, low Apgar score at 5 minute, resuscitation of newborn  and admission in NICU in pregnancy with oligohydramnios was higher in preterm and term pregnancies. Whereas, in other studies there was no difference between groups presenting a 5 minute Apgar less than 7 (4, 5, 7). But similar to us, some authors showed a significantly higher percentage of NICU admission in infants born in normal AFI group in comparison to those with oligohydramnios (5, 7, 8).

 

 Women in the oligohydramnios group also had a significantly higher rate of neonatal mortality in 24 hours after birth but no still birth. Casey et al. showed that oligohydramnios is associated with neonatal death and still birth (8). We have found that oligohydramnios is not associated with lower birth weight (< 10th percentile). Whereas, some authors reported a relationship between oligohydramnios and neonatal birth weight (4, 8).

 

In conclusion, according to our study, because of high morbidity in oligohydramnios pregnancies, appropriate prenatal care and fetal monitoring, timed pregnancy termination  and suitable cooperation between obstetrician and pediatrician should be performed.

 

Acknowledgments:  

We would like to thank Babol University of Medical Sciences for their support.

 

Conflict of interests:

The Authors declared no conflict of interest.

 

    References                                                     

 

1.      Cunningham F G, Leveno K, Bloom S, et al. Spong CY Williams Obstetrics. Williams Obstetrics. 22 ed: USA: The McGraw-Hill Companies, Inc. Medical Publishing Division, 2010:59-61 & 491-96.

2.      Manning F A, Platt L D, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. American journal of obstetrics and gynecology. 1980;136(6):787-95.

3.      Volante E, Gramellini D, Moretti S, et al. Alteration of the amniotic fluid and neonatal outcome. Acta Biomed. 2004;75(Suppl 1):71-5.

4.      Locatelli A, Vergani P, Toso L, et al. Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies. Archives of gynecology and obstetrics. 2004;269(2):130-33.

5.      Alchalabi H A, Obeidat B R, Jallad M F, Khader Y S. Induction of labor and perinatal outcome: the impact of the amniotic fluid index. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2006;129(2):124-27.

6.      Hasegawa J, Matsuoka R, Ichizuka K, et al. Intrapartum fetal heart rate pattern in oligohydramnios. Fetal diagnosis and therapy. 2008;24(3):267-70.

7.      Voxman E G, Tran S, Wing D A. Low amniotic fluid index as a predictor of adverse perinatal outcome. Journal of perinatology: official journal of the California Perinatal Association. 2002;22(4):282-85.

8.      Casey B M, McIntire D D, Bloom S L, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation. American journal of obstetrics and gynecology. 2000;182(4):909-12.

9.      Chen C-M, Chou H-C, Wang L-F, Lang Y-D. Experimental oligohydramnios decreases collagen in hypoplastic fetal rat lungs. Experimental Biology and Medicine. 2008;233(11):1334-40.

10.   Winn H N, Chen M, Amon E, et al. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes—a critical analysis. American journal of obstetrics and gynecology. 2000;182(6):1638-44.

11.   Garmel S H, Chelmow D, Sandra J S, et al. Oligohydramnios and the appropriately grown fetus. American journal of perinatology. 1997;14(06):359-63.

12.   Barksdale E, Chwals W, Magnuson D, Parry R. Fanaroff and Martin's neonatal-perinatal medicine. Fanaroff and Martin's neonatal-perinatal medicine. 9 ed: Mosby Elsevier 2010:629.

13.   Fenton T R. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC pediatrics. 2003;3(1):13.

14.   Cloherty J P, Eichenwald E C, Stark A R. Manual of neonatal care. 6 ed: Lippincott Williams & Wilkins, 2008.

15.   Banks E H, Miller D A. Perinatal risks associated with borderline amniotic fluid index. American journal of obstetrics and gynecology. 1999;180(6):1461-63.

16.   Golan A, Lin G, Evron S, et al. Oligohydramnios: maternal complications and fetal outcome in 145 cases. Gynecologic and obstetric investigation. 1994;37(2):91-95.